US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ヨーロッパ
EU
Reboost Blockchain Corp (MLCOT) 銘柄情報

Reboost Blockchain Corp (MLCOT)

0.075

0.00

(0.00%)

終了 7月5日 12:30AM

Reboost Blockchain Corp (MLCOT) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.075

( - )

買値

0.00

売値

0.00

出来高

0.00

0.00 日の範囲 0.00

0.075 52 週間の範囲 0.24

時価総額

前日終値

0.075

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

72,600 €

発行済株式数

13,406,759

配当利回り

PER

-

1 株当たり利益 (EPS)

-

歳入

15.35k

純利益

21.09k

Reboost Blockchain Corp., an investment company in technology companies and securing decentralized protocols. The company was formerly known as Coretech 5 Société anonyme. The company was founded in 2014 and is based in Paris, France. Reboost Blockchain Corp., an investment company in technology companies and securing decentralized protocols. The company was formerly known as Coretech 5 Société anonyme. The company was founded in 2014 and is based in Paris, France.

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

reboostblockchaincorp.com

本社

Paris, France

設立

2026

Reboost Blockchain Corp is listed in the Healthcare sector of the ユーロネクスト with ticker MLCOT. The last closing price for Reboost Blockchain was 0.08 €. Over the last year, Reboost Blockchain shares have traded in a share price range of 0.075 € to 0.24 €.

Reboost Blockchain currently has 13,406,759 shares in issue. The market capitalisation of Reboost Blockchain is 1.01 € million.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.075	0.075	0.075	0	0	DE
4	0	0	0.075	0.075	0.075	0	0	DE
12	0	0	0.075	0.075	0.075	0	0	DE
26	-0.039	-34.2105263158	0.114	0.12	0.075	959	0.1016662	DE
52	-0.125	-62.5	0.2	0.24	0.075	6948	0.1608889	DE
156	0.025	50	0.05	0.256	0.005	12220	0.07206342	DE
260	0.025	50	0.05	0.256	0.005	12220	0.07206342	DE

MLCOT - Frequently Asked Questions (FAQ)

What is the current Reboost Blockchain Corp share price?

The current share price of Reboost Blockchain Corp is 0.075 €

How many Reboost Blockchain Corp shares are in issue?

Reboost Blockchain Corp has 13,406,759 shares in issue

What is the market cap of Reboost Blockchain Corp?

The market capitalisation of Reboost Blockchain Corp is EUR 1.01M

What is the 1 year trading range for Reboost Blockchain Corp share price?

Reboost Blockchain Corp has traded in the range of 0.075 € to 0.24 € during the past year

What is the cash to sales ratio of Reboost Blockchain Corp?

The cash to sales ratio of Reboost Blockchain Corp is 78.6

What is the registered address of Reboost Blockchain Corp?

The registered address for Reboost Blockchain Corp is 5, rue de Castiglione, Paris, Ile-de-France, 75001

What is the Reboost Blockchain Corp website address?

The website address for Reboost Blockchain Corp is reboostblockchaincorp.com

Which industry sector does Reboost Blockchain Corp operate in?

Reboost Blockchain Corp operates in the Pharmaceuticals sector

gfp927z

gfp927z 3分前

US Stablecoin consortium -

A huge development last week for the coming US national Stablecoin system. 140 of the biggest players in finance are forming a consortium to run and own the new US digital dollar / stablecoin system they call 'Open US' (links below). The stablecoin is lik

gfp927z

gfp927z 7分前

Bigworld, It looks like a huge development last week for the coming US national Stablecoin system. 140 of the biggest players in finance are forming a consortium to run and own the new US digital dollar / stablecoin system they call 'Open US' (links below). The stablecoin is like a CBDC (digital

Twiggs333

Twiggs333 27分前

GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G

Twiggs333

Twiggs333 28分前

GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G

Twiggs333

Twiggs333 28分前

GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G

Twiggs333

Twiggs333 28分前

GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G

OMOLIVES

OMOLIVES 32分前

Happy Fourth of July to all!...and a big thank you to the French. Vive la France!:

https://x.com/Phoenix2A_1980s/status/2073453266428387385

4u2nv2

4u2nv2 34分前

Every filing from the time Paul and Ben took over said there were 3 preferred shareholders. The third one was never named. Now, it's interesting to question how Newby got controlling interest when we do not know all of the facts concerning what Ben really wanted to accomplish with taking on the comm

Eli's Gone

Eli's Gone 45分前

I'm in: 11-5-24-19

Eli's Gone

Eli's Gone 46分前

gfp927z

gfp927z 47分前

>>> Look At Who Joined Open USD To Understand Where Money Is Going

Forbes

by Zennon Kapron

Jul 02, 2026

https://www.forbes.com/sites/digital-assets/2026/07/02/look-at-who-joined-open-usd-to-understand-where-money-is-going/

Sammy boy

Sammy boy 52分前

Said it 4 months ago Bessent is the problem ! There is a reason he cold-cocked Tommy Boy.

misterfishman

misterfishman 1時間前

Me too my side hobbies are researching new forms of energy from the enviroment,been at this for more than 20 yrs now and have accumilated a great deal oh knowledge.

Atlanta1

Atlanta1 1時間前

Joey - Why do you waste time on this lunatic?

FeMike

FeMike 1時間前

The original randomised primary endpoint (PFS) was negative and showed harm,

The simple fact that you don’t understand pseudo progression is more than enough to establish as also fact that you have no idea what you’re talking about.

1jas

1jas 1時間前

If you go to otcmarkets for AFFU news dated August 22 2023 it does mention AFFU and Dell partnership.

nyt

3 yrs down 79%. 5 yrs down 57%. 10 yrs down over 80%

gemstone57

gemstone57 1時間前

Happy Fourth of July guys we live in the greatest Nation on earth.

Tadaaa

Tadaaa 2時間前

johnydollar

johnydollar 2時間前

Have you ever wondered why clown fish like to hang out around the sea anemones........

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆

GoodGuyBill

GoodGuyBill 2時間前

rcbindustry

rcbindustry 2時間前

I'm staying on the sidelines for now. Rocket Companies has potential over the long term, but I think the stock will continue to depend heavily on interest rates and the housing market. I'll be watching the next few quarters before becoming more optimistic.

Genz2

Genz2 2時間前

Now who would have thought of what Steven K Sprague came up with on X recently??? This country, Microsoft, Intel and Wave need Steven’s thinking!!!! If Steven’s court case is still in abeyance that is a real travesty!!! Steven is VERY UNIQUE in how he can masterfully come up with solutions that a

johnydollar

johnydollar 2時間前

You mean naked short enrichment right...........

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 Ƕ

Roman516

Roman516 2時間前

Happy 4th of July to all, GoodGuyBill, yes, I agree with you and your comment that "$35 billion is far too low for a treatment that will treat all tumor-based cancers (and we are not even discussing DIRECT, the combo patent, etc)."

If in fact, DCVax-D is able to address the majority o

Reboost Blockchain

SID NACIONAL ON

NS United Kaiun Ka (PK)

BMO Nasdaq 100 Equity He...

Tencent Music Entertainm...

2875% until 05/25/2027 2...

Amundi Core FTSE 100 Swa...

Falcon Oil plus Gas

Xtract One Technologies

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。